Comparison of Total Tubeless Mini-PCNL Versus Tubeless Mini-PCNL
NCT ID: NCT06288022
Last Updated: 2024-03-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
130 participants
INTERVENTIONAL
2024-04-01
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This Randomized Controlled trial aims to compare complication and safety of Mini-PCNL between total tubeless and tubeless Mini-PCNL.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mini-PCNL Versus Standard-PCNL For The Management of 20-40 mm Size Kidney Stones
NCT02635048
Standard vs Mini-PCNL for the Treatment of Stone Disease
NCT04069013
Mini-PNCL vs fURS in Management of Nephrolithiasis
NCT04389853
Suction Mini-PCNL Versus Standard PCNL for the Management of 2-4cm Kidney Stones
NCT05088213
The 18F Peel-way Sheath Versus the 18F Access Sheath With a Suction-evacuation Function MPCNL for the Management of 2-5cm Size Kidney Stones
NCT03206515
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
1. total tubeless mini-PCNL
2. tubeless mini-PCNL
OTHER
DOUBLE
Patient will participate or not depends on whether they not meet the surgical exclusion criteria. If they meet the criteria, they will not participate in the research. If they not meet the criteria, they will be randomly assigned to one of the groups.
Patients will not be informed of the treatment intervention in advance
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
total tubeless mini-PCNL
When finish the mini-PCNL operation, patient not receive placement both ureteral drainage tube (DJ-stent) and nephrostomy tube.
total tubeless mini-PCNL
When finish the mini-PCNL operation, patient not receive placement both ureteral drainage tube (DJ-stent) and nephrostomy tube.
tubeless mini-PCNL
When finish the mini-PCNL operation, patient receive placement ureteral drainage tube (DJ-stent) but not receive nephrostomy tube.
tubeless mini-PCNL
When finish the mini-PCNL operation, patient receive placement ureteral drainage tube (DJ-stent) but not receive nephrostomy tube.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
total tubeless mini-PCNL
When finish the mini-PCNL operation, patient not receive placement both ureteral drainage tube (DJ-stent) and nephrostomy tube.
tubeless mini-PCNL
When finish the mini-PCNL operation, patient receive placement ureteral drainage tube (DJ-stent) but not receive nephrostomy tube.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients have undergone mini-PCNL, unilateral
* Absence of urinary tract infections before surgery.
* No urological congenital abnormality
* No coagulopathy
Exclusion Criteria
* Patients with a single functioning kidney
* Complicated cases, including:
1. massive bleeding in the upper tract during surgery
2. Severe collecting systems injury during surgery
3. Severe UPJ mucosa swelling considered unsafe by the physician, requiring the placement of a DJ stent or nephostomy tube
* Participants who decline or request withdrawal from the research study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mahidol University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thanakorn Sirajarus
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
THANAKORN SIRAJARUS
Role: PRINCIPAL_INVESTIGATOR
Ramathibodi Hospital, Mahidol University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ramathibodi Hospital, Mahidol University
Bangkok, Ratchathewi, Thailand
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COA. MURA2023/947
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.